Evaluating the benefit/risk and safety profile of PCSK9 inhibitors - Clinical and economic implications
1 September 2019 (13:30 - 13:45)
Organised by:
About the speaker
Baylor College of Medicine, Houston (United States of America)
5 More presentations in this session
Professor F. Schiele (Besancon, FR)
Professor J. Jukema (Leiden, NL)
Professor J. Jukema (Leiden, NL)
Professor F. Schiele (Besancon, FR)
Doctor C. Ballantyne (Houston, US)
Professor J. Jukema (Leiden, NL)
Professor F. Schiele (Besancon, FR)
Doctor C. Ballantyne (Houston, US)
Access the full session
The Event
ESC Congress 2019
1 September 2019
13:30 CET
/f/125658/640x360/c39f4547b4/ett-s3-ep7.jpg)
